Loading…
Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group
Hepatitis C virus (HCV) has emerged as an important etiologic agent of liver injury and failure in patients infected with human immunodeficiency virus (HIV). The prevalence and characteristics of HCV in a representative cohort of HIV-infected patients have not been described. Therefore, a representa...
Saved in:
Published in: | Clinical infectious diseases 2002-03, Vol.34 (6), p.831-837 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c385t-f09e2553f82f1112fdfb8b33a603679c0bb97bb212df1048cf08f63949ea260f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c385t-f09e2553f82f1112fdfb8b33a603679c0bb97bb212df1048cf08f63949ea260f3 |
container_end_page | 837 |
container_issue | 6 |
container_start_page | 831 |
container_title | Clinical infectious diseases |
container_volume | 34 |
creator | Sherman, Kenneth E. Rouster, Susan D. Chung, Raymond T. Rajicic, Natasa |
description | Hepatitis C virus (HCV) has emerged as an important etiologic agent of liver injury and failure in patients infected with human immunodeficiency virus (HIV). The prevalence and characteristics of HCV in a representative cohort of HIV-infected patients have not been described. Therefore, a representative sample of 1687 HIV-infected patients was studied; a 213-sample subcohort was selected by use of risk-based sampling from 2 large prospective US Adult AIDS Clinical Trials Group clinical trials. HCV prevalence, HCV RNA level, and genotype were determined. The weighted overall estimate of HCV prevalence in the study cohort was 16.1% (95% weighted confidence interval, 14.3%–17.8%), with significant variability depending on risk factors and HIV RNA levels. Among patients defined as being “at risk,” 72.7% were HCV positive, whereas, among low-risk patients, the positivity rate was 3.5%. Genotype 1 was found in 83.3% of infected patients. Median HCV RNA level was 6.08 × 106 IU/mL. High virus loads and genotype 1 prevalence may be important to interferon-based antiviral response rates among coinfected patients. |
doi_str_mv | 10.1086/339042 |
format | article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_71453734</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4461975</jstor_id><oup_id>10.1086/339042</oup_id><sourcerecordid>4461975</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-f09e2553f82f1112fdfb8b33a603679c0bb97bb212df1048cf08f63949ea260f3</originalsourceid><addsrcrecordid>eNqF0VFv1SAUAODGaNyc-guMwQd9q0KBQvfWdHO9ZomLd1uML4RScMyWXoFO74_xv8rSm90n4wsHcj7OSc7JspcIvkeQlx8wriApHmWHiGKWl7RCj9MdUp4TjvlB9iyEWwgR4pA-zQ5SxBhCdpj9afVGRhttAA24tn4O4MLrOzlopzSQ4-S-g4sEtIsBrJzRKuoe_LLxBrTzKB1YjePspl4bqxJS26XIMahB46cQ8nX6YScnB1CnYxtSo8mAeKPB1RrU_TxEUK9O1qAZrLMqsUtv5RDAmZ_mzfPsiUkP_WIXj7Krj6eXTZuffz5bNfV5rjCnMTew0gWl2PDCIIQK05uOdxjLEuKSVQp2XcW6rkBFbxAkXBnITYkrUmlZlNDgo-zdUnfjp5-zDlGMNig9DNLpaQ6CIZLGisl_IeKkZBzyPVT3U_DaiI23o_RbgaC435hYNpbg613FuRt1v2e7FSXwdgdkSPMxXjplw95hSiAtUHJvFpfm9u9mrxZzG-LkHxQhJaoYTel8SdsQ9e-HtPQ_RMkwo6L9-k1QcvLpS3XdijX-C91rv7c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18467808</pqid></control><display><type>article</type><title>Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford Journals Online</source><creator>Sherman, Kenneth E. ; Rouster, Susan D. ; Chung, Raymond T. ; Rajicic, Natasa</creator><creatorcontrib>Sherman, Kenneth E. ; Rouster, Susan D. ; Chung, Raymond T. ; Rajicic, Natasa</creatorcontrib><description>Hepatitis C virus (HCV) has emerged as an important etiologic agent of liver injury and failure in patients infected with human immunodeficiency virus (HIV). The prevalence and characteristics of HCV in a representative cohort of HIV-infected patients have not been described. Therefore, a representative sample of 1687 HIV-infected patients was studied; a 213-sample subcohort was selected by use of risk-based sampling from 2 large prospective US Adult AIDS Clinical Trials Group clinical trials. HCV prevalence, HCV RNA level, and genotype were determined. The weighted overall estimate of HCV prevalence in the study cohort was 16.1% (95% weighted confidence interval, 14.3%–17.8%), with significant variability depending on risk factors and HIV RNA levels. Among patients defined as being “at risk,” 72.7% were HCV positive, whereas, among low-risk patients, the positivity rate was 3.5%. Genotype 1 was found in 83.3% of infected patients. Median HCV RNA level was 6.08 × 106 IU/mL. High virus loads and genotype 1 prevalence may be important to interferon-based antiviral response rates among coinfected patients.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/339042</identifier><identifier>PMID: 11833007</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Adult ; AIDS ; AIDS-Related Opportunistic Infections - epidemiology ; AIDS-Related Opportunistic Infections - virology ; Biological and medical sciences ; Clinical Trials as Topic ; Coinfection ; Cross-Sectional Studies ; Female ; Genotypes ; Hemophilia ; Hepacivirus ; Hepacivirus - genetics ; Hepacivirus - isolation & purification ; Hepatitis C - blood ; Hepatitis C - epidemiology ; Hepatitis C - etiology ; HIV ; HIV Infections - blood ; HIV Infections - complications ; HIV/AIDS ; Human viral diseases ; Humans ; Infections ; Infectious diseases ; Lymphocytes ; Male ; Medical sciences ; Middle Aged ; Prevalence ; RNA ; RNA, Viral - blood ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral hepatitis ; Viruses</subject><ispartof>Clinical infectious diseases, 2002-03, Vol.34 (6), p.831-837</ispartof><rights>Copyright 2002 The Infectious Diseases Society of America</rights><rights>2002 by the Infectious Diseases Society of America 2002</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-f09e2553f82f1112fdfb8b33a603679c0bb97bb212df1048cf08f63949ea260f3</citedby><cites>FETCH-LOGICAL-c385t-f09e2553f82f1112fdfb8b33a603679c0bb97bb212df1048cf08f63949ea260f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4461975$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4461975$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13540521$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11833007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sherman, Kenneth E.</creatorcontrib><creatorcontrib>Rouster, Susan D.</creatorcontrib><creatorcontrib>Chung, Raymond T.</creatorcontrib><creatorcontrib>Rajicic, Natasa</creatorcontrib><title>Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>Hepatitis C virus (HCV) has emerged as an important etiologic agent of liver injury and failure in patients infected with human immunodeficiency virus (HIV). The prevalence and characteristics of HCV in a representative cohort of HIV-infected patients have not been described. Therefore, a representative sample of 1687 HIV-infected patients was studied; a 213-sample subcohort was selected by use of risk-based sampling from 2 large prospective US Adult AIDS Clinical Trials Group clinical trials. HCV prevalence, HCV RNA level, and genotype were determined. The weighted overall estimate of HCV prevalence in the study cohort was 16.1% (95% weighted confidence interval, 14.3%–17.8%), with significant variability depending on risk factors and HIV RNA levels. Among patients defined as being “at risk,” 72.7% were HCV positive, whereas, among low-risk patients, the positivity rate was 3.5%. Genotype 1 was found in 83.3% of infected patients. Median HCV RNA level was 6.08 × 106 IU/mL. High virus loads and genotype 1 prevalence may be important to interferon-based antiviral response rates among coinfected patients.</description><subject>Adult</subject><subject>AIDS</subject><subject>AIDS-Related Opportunistic Infections - epidemiology</subject><subject>AIDS-Related Opportunistic Infections - virology</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Coinfection</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Genotypes</subject><subject>Hemophilia</subject><subject>Hepacivirus</subject><subject>Hepacivirus - genetics</subject><subject>Hepacivirus - isolation & purification</subject><subject>Hepatitis C - blood</subject><subject>Hepatitis C - epidemiology</subject><subject>Hepatitis C - etiology</subject><subject>HIV</subject><subject>HIV Infections - blood</subject><subject>HIV Infections - complications</subject><subject>HIV/AIDS</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>RNA</subject><subject>RNA, Viral - blood</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral hepatitis</subject><subject>Viruses</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqF0VFv1SAUAODGaNyc-guMwQd9q0KBQvfWdHO9ZomLd1uML4RScMyWXoFO74_xv8rSm90n4wsHcj7OSc7JspcIvkeQlx8wriApHmWHiGKWl7RCj9MdUp4TjvlB9iyEWwgR4pA-zQ5SxBhCdpj9afVGRhttAA24tn4O4MLrOzlopzSQ4-S-g4sEtIsBrJzRKuoe_LLxBrTzKB1YjePspl4bqxJS26XIMahB46cQ8nX6YScnB1CnYxtSo8mAeKPB1RrU_TxEUK9O1qAZrLMqsUtv5RDAmZ_mzfPsiUkP_WIXj7Krj6eXTZuffz5bNfV5rjCnMTew0gWl2PDCIIQK05uOdxjLEuKSVQp2XcW6rkBFbxAkXBnITYkrUmlZlNDgo-zdUnfjp5-zDlGMNig9DNLpaQ6CIZLGisl_IeKkZBzyPVT3U_DaiI23o_RbgaC435hYNpbg613FuRt1v2e7FSXwdgdkSPMxXjplw95hSiAtUHJvFpfm9u9mrxZzG-LkHxQhJaoYTel8SdsQ9e-HtPQ_RMkwo6L9-k1QcvLpS3XdijX-C91rv7c</recordid><startdate>20020315</startdate><enddate>20020315</enddate><creator>Sherman, Kenneth E.</creator><creator>Rouster, Susan D.</creator><creator>Chung, Raymond T.</creator><creator>Rajicic, Natasa</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20020315</creationdate><title>Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group</title><author>Sherman, Kenneth E. ; Rouster, Susan D. ; Chung, Raymond T. ; Rajicic, Natasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-f09e2553f82f1112fdfb8b33a603679c0bb97bb212df1048cf08f63949ea260f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>AIDS</topic><topic>AIDS-Related Opportunistic Infections - epidemiology</topic><topic>AIDS-Related Opportunistic Infections - virology</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Coinfection</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Genotypes</topic><topic>Hemophilia</topic><topic>Hepacivirus</topic><topic>Hepacivirus - genetics</topic><topic>Hepacivirus - isolation & purification</topic><topic>Hepatitis C - blood</topic><topic>Hepatitis C - epidemiology</topic><topic>Hepatitis C - etiology</topic><topic>HIV</topic><topic>HIV Infections - blood</topic><topic>HIV Infections - complications</topic><topic>HIV/AIDS</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>RNA</topic><topic>RNA, Viral - blood</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral hepatitis</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sherman, Kenneth E.</creatorcontrib><creatorcontrib>Rouster, Susan D.</creatorcontrib><creatorcontrib>Chung, Raymond T.</creatorcontrib><creatorcontrib>Rajicic, Natasa</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sherman, Kenneth E.</au><au>Rouster, Susan D.</au><au>Chung, Raymond T.</au><au>Rajicic, Natasa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2002-03-15</date><risdate>2002</risdate><volume>34</volume><issue>6</issue><spage>831</spage><epage>837</epage><pages>831-837</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>Hepatitis C virus (HCV) has emerged as an important etiologic agent of liver injury and failure in patients infected with human immunodeficiency virus (HIV). The prevalence and characteristics of HCV in a representative cohort of HIV-infected patients have not been described. Therefore, a representative sample of 1687 HIV-infected patients was studied; a 213-sample subcohort was selected by use of risk-based sampling from 2 large prospective US Adult AIDS Clinical Trials Group clinical trials. HCV prevalence, HCV RNA level, and genotype were determined. The weighted overall estimate of HCV prevalence in the study cohort was 16.1% (95% weighted confidence interval, 14.3%–17.8%), with significant variability depending on risk factors and HIV RNA levels. Among patients defined as being “at risk,” 72.7% were HCV positive, whereas, among low-risk patients, the positivity rate was 3.5%. Genotype 1 was found in 83.3% of infected patients. Median HCV RNA level was 6.08 × 106 IU/mL. High virus loads and genotype 1 prevalence may be important to interferon-based antiviral response rates among coinfected patients.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>11833007</pmid><doi>10.1086/339042</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1058-4838 |
ispartof | Clinical infectious diseases, 2002-03, Vol.34 (6), p.831-837 |
issn | 1058-4838 1537-6591 |
language | eng |
recordid | cdi_proquest_miscellaneous_71453734 |
source | JSTOR Archival Journals and Primary Sources Collection; Oxford Journals Online |
subjects | Adult AIDS AIDS-Related Opportunistic Infections - epidemiology AIDS-Related Opportunistic Infections - virology Biological and medical sciences Clinical Trials as Topic Coinfection Cross-Sectional Studies Female Genotypes Hemophilia Hepacivirus Hepacivirus - genetics Hepacivirus - isolation & purification Hepatitis C - blood Hepatitis C - epidemiology Hepatitis C - etiology HIV HIV Infections - blood HIV Infections - complications HIV/AIDS Human viral diseases Humans Infections Infectious diseases Lymphocytes Male Medical sciences Middle Aged Prevalence RNA RNA, Viral - blood Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral hepatitis Viruses |
title | Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A37%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatitis%20C%20Virus%20Prevalence%20among%20Patients%20Infected%20with%20Human%20Immunodeficiency%20Virus:%20A%20Cross-Sectional%20Analysis%20of%20the%20US%20Adult%20AIDS%20Clinical%20Trials%20Group&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Sherman,%20Kenneth%20E.&rft.date=2002-03-15&rft.volume=34&rft.issue=6&rft.spage=831&rft.epage=837&rft.pages=831-837&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/339042&rft_dat=%3Cjstor_proqu%3E4461975%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c385t-f09e2553f82f1112fdfb8b33a603679c0bb97bb212df1048cf08f63949ea260f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18467808&rft_id=info:pmid/11833007&rft_jstor_id=4461975&rft_oup_id=10.1086/339042&rfr_iscdi=true |